TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Bio Vitos Pharma AB
Closing information (x1000 SEK)
Closing information | 2023/12 (consolidated) | 2022/12 | 2021/12 |
Turnover |
2,996
|
1,320
|
1,121 |
Financial expenses |
0
![]() |
0
|
1 |
Earnings before taxes |
-12,867
|
-14,900
|
-13,954 |
EBITDA |
-3,504
|
-7,775
|
-7,534 |
Total assets |
33,919
|
26,450
|
35,497 |
Current assets |
5,112
|
5,222
|
11,099 |
Current liabilities |
1,008
|
1,527
|
1,962 |
Equity capital |
32,911
|
24,923
|
33,535 |
- share capital |
4,278
|
3,093
|
1,736 |
Employees (average) |
1
|
5
|
6 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 | 2021/12 |
Solvency |
97.0%
|
94.2%
|
94.5% |
Turnover per employee |
2,996
|
264
|
187 |
Profit as a percentage of turnover |
-429.5%
|
-1128.8%
|
-1244.8% |
Return on assets (ROA) |
-37.9%
|
-56.3%
|
-39.3% |
Current ratio |
507.1%
|
342.0%
|
565.7% |
Return on equity (ROE) |
-39.1%
|
-59.8%
|
-41.6% |
Change turnover | |||
Change turnover % |
18%
|
265% | |
Chg. No. of employees | |||
Chg. No. of employees % |
-17%
|
20% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.